Functional biomarker platform
Measures cancer cell survival dependencies on BCL-2 family proteins to guide apoptosis-targeted therapies in AML and other hematologic malignancies.
Source: LinkedIn company description · Retrieved October 13, 2026
Eutropics Pharmaceuticals is developing a functional biomarker platform.
The platform measures cancer cell survival dependencies on BCL-2 family proteins to guide apoptosis-targeted therapies in AML and other hematologic malignancies. PRIMAB-Dx is being validated within a CLIA framework, unlike research-grade functional assays.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Measures cancer cell survival dependencies on BCL-2 family proteins to guide apoptosis-targeted therapies in AML and other hematologic malignancies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 13, 2026, September 15, 2026, September 18, 2026, September 19, 2026, October 8, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.